CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Retained Earnings	Non-controlling Interests
Beginning Balance at Apr. 29, 2023	$ 1,118,535	$ 964	$ 233,706	$ (89,262)	$ 972,127	$ 1,000
Beginning Balance (in shares) at Apr. 29, 2023		96,350,000
Foreign currency translation	7,368			7,368
Cash flow hedges	261			261
Net income (loss)	31,130				31,234	(104)
Dividends declared	(25,134)				(25,134)
Common stock issued	1,574	$ 5	1,569
Common stock issued and related tax benefits (in shares)		565,000
Repurchases of common stock	(29,508)	$ (11)			(29,497)
Repurchases of common stock (in shares)		(1,109,000)
Stock-based compensation	7,015		7,015
Ending Balance at Jul. 29, 2023	1,111,241	$ 958	242,290	(81,633)	948,730	896
Ending Balance (in shares) at Jul. 29, 2023		95,806,000
Foreign currency translation	(17,589)			(17,589)
Cash flow hedges	260			260
Net income (loss)	39,855				39,958	(103)
Dividends declared	(24,897)				(24,897)
Common stock issued	3,228	$ 2	3,226
Common stock issued and related tax benefits (in shares)		180,000
Repurchases of common stock	(61,644)	$ (19)	(661)		(60,964)
Repurchases of common stock (in shares)		(1,897,000)
Stock-based compensation	4,635		4,635
Ending Balance at Oct. 28, 2023	1,055,089	$ 941	249,490	(98,962)	902,827	793
Ending Balance (in shares) at Oct. 28, 2023		94,089,000
Foreign currency translation	12,538			12,538
Cash flow hedges	261			261
Net income (loss)	47,593				47,703	(110)
Dividends declared	(23,591)				(23,591)
Common stock issued	1,845	$ 1	1,844
Common stock issued and related tax benefits (in shares)		103,000
Repurchases of common stock	(125,315)	$ (41)	(1,219)		(124,055)
Repurchases of common stock (in shares)		(4,101,000)
Stock-based compensation	3,745		3,745
Ending Balance at Jan. 27, 2024	972,165	$ 901	253,860	(86,163)	802,884	683
Ending Balance (in shares) at Jan. 27, 2024		90,091,000
Foreign currency translation	(4,012)			(4,012)
Cash flow hedges	260			260
Net income (loss)	66,941				67,036	(95)
Dividends declared	(23,521)				(23,521)
Common stock issued	2,463	$ 1	2,462
Common stock issued and related tax benefits (in shares)		107,000
Repurchases of common stock	(15,040)	$ (5)	(119)		(14,916)
Repurchases of common stock (in shares)		(497,000)
Stock-based compensation	2,476		2,476
Ending Balance at Apr. 27, 2024	$ 1,001,732	$ 897	258,679	(89,915)	831,483	588
Ending Balance (in shares) at Apr. 27, 2024	89,701,000	89,701,000
Foreign currency translation	$ 3,181			3,181
Cash flow hedges	261			261
Net income (loss)	13,639				13,715	(76)
Dividends declared	(23,221)				(23,221)
Common stock issued	(748)	$ 4	(752)
Common stock issued and related tax benefits (in shares)		385,000
Repurchases of common stock	(50,403)	$ (20)	(403)		(49,980)
Repurchases of common stock (in shares)		(1,940,000)
Stock-based compensation	8,060		8,060
Ending Balance at Jul. 27, 2024	$ 952,501	$ 881	$ 265,584	$ (86,473)	$ 771,997	$ 512
Ending Balance (in shares) at Jul. 27, 2024	88,146,000	88,146,000